Xencor (XNCR) Short-term Investments (2015 - 2026)
Xencor (XNCR) reported Short-term Investments of $60.6 million for Q1 2026, down 84.1% year-over-year from $381.0 million in Q1 2025, and down 46.16% quarter-over-quarter from $112.5 million in Q4 2025.
Xencor (XNCR) Short-term Investments (2015 - 2026) Analysis & Trends
Xencor (XNCR) has 12 years of Short-term Investments data on file, last reported at $60.6 million in Q1 2026.
- Short-term Investments for Q1 2026 came in at $60.6 million, down 84.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.6 million (down 84.1% YoY), and the FY2025 annual result was $112.5 million, up 134.73% from the prior year.
- Short-term Investments retreated to $60.6 million in Q1 2026 per XNCR's latest filing, from $112.5 million in the prior quarter.
- Over five years, Short-term Investments peaked at $526.7 million in Q4 2022 and troughed at $33.4 million in Q1 2022.
- A 5-year average of $279.4 million and a median of $359.0 million in 2025 frame the typical range for Short-term Investments.
- On a YoY basis, Short-term Investments climbed as much as 1328.89% in 2022 and fell as far as 90.94% in 2022.
- A 5-year view of Short-term Investments shows it stood at $526.7 million in 2022, then slipped by 5.5% to $497.7 million in 2023, then sank by 90.37% to $47.9 million in 2024, then surged by 134.73% to $112.5 million in 2025, then plunged by 46.16% to $60.6 million in 2026.
- Business Quant data shows XNCR's Short-term Investments at $60.6 million in Q1 2026, $112.5 million in Q4 2025, and $358.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.57 Mn |
| Dec 31, 2025 | 112.50 Mn |
| Sep 30, 2025 | 358.49 Mn |
| Jun 30, 2025 | 358.98 Mn |
| Mar 31, 2025 | 381.02 Mn |
| Dec 31, 2024 | 47.93 Mn |
| Sep 30, 2024 | 435.04 Mn |
| Jun 30, 2024 | 449.37 Mn |
| Mar 31, 2024 | 44.54 Mn |
| Dec 31, 2023 | 497.73 Mn |
| Sep 30, 2023 | 412.83 Mn |
| Jun 30, 2023 | 40.00 Mn |
| Mar 31, 2023 | 39.71 Mn |
| Dec 31, 2022 | 526.69 Mn |
| Sep 30, 2022 | 515.40 Mn |
| Jun 30, 2022 | 435.62 Mn |
| Mar 31, 2022 | 33.43 Mn |
| Dec 31, 2021 | 36.86 Mn |
| Sep 30, 2021 | 47.58 Mn |
| Jun 30, 2021 | 45.23 Mn |